• Panobinostat (LBH589) Cancer Research Workflows

  2026-08-28

  Panobinostat (LBH589) combines broad-spectrum HDAC inhibition with practical readouts for epigenetic regulation, apoptosis, and therapy resistance. This workflow-focused guide shows how to connect histone acetylation and cell-death assays with the emerging RNA Pol II degradation-dependent apoptotic response without confusing correlation with mechanism.

• Taltirelin Acetate: From Receptor to Translation

  2026-08-27

  Taltirelin acetate is more than a long-acting TRH analog: it is a translational tool for connecting TRHR1 signaling with dopaminergic resilience, airway motor control, itch biology, and formulation strategy. This article outlines how to design evidence-led studies while separating demonstrated mechanisms from hypotheses that still require validation.

• Carvedilol Phosphate: A Causal IRI Assay Framework

  2026-08-27

  Carvedilol Phosphate can do more than alter adrenergic tone in an ischemia–reperfusion injury model. This article presents a causal assay framework for separating hepatocyte signaling, macrophage polarization, metabolite changes, and formulation artifacts.

• AICAR phosphate (Acadesine) Assay Guide

  2026-08-26

  A scenario-based guide to using AICAR phosphate (Acadesine), SKU B1211, in viability, proliferation, and apoptosis workflows. It connects AMPK activation with dose-response design, mitochondrial cytochrome c release, caspase activation, formulation control, and evidence-based product selection.

• DFCP1 Controls ATGL-Driven Lipolysis Under Starvation

  2026-08-26

  The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of lipid droplet catabolism that acts through ATGL, the rate-limiting enzyme in triglyceride hydrolysis. Its central advance is showing that DFCP1 recruits ATGL to lipid droplets during starvation but restricts ATGL mobility, thereby slowing lipolysis rather than simply increasing enzyme delivery.

• Intravesical p21 mRNA–LNP Therapy in Bladder Cancer

  2026-08-25

  This 2026 FASEB Journal study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, inhibited tumor-cell proliferation, and suppressed orthotopic tumor growth while limiting systemic exposure, although formulation-specific and clinical questions remain unresolved.

• AZD2461: Practical Workflows for PARP Research

  2026-08-25

  AZD2461 is a novel PARP inhibitor for separating DNA repair pathway modulation, growth arrest, and cell death in cancer models. Its lower P-glycoprotein affinity creates a useful experimental angle for breast cancer research and studies of resistance that may be missed with olaparib alone.

• Laminin (925-933): Cell Adhesion & Chemotaxis

  2026-08-24

  Laminin (925-933) is a defined Laminin B1 chain peptide for receptor-focused studies of cell adhesion, migration, and chemotaxis. Product data support attachment and chemotactic-response assays, while current organoid literature supports laminin as an extracellular-matrix component but does not establish this peptide as an organoid treatment.

• Isorhamnetin for Reliable Cell Assays

  2026-08-23

  This scenario-based guide explains how Isorhamnetin, SKU N1358, can be incorporated into cell viability, proliferation, apoptosis, and oxidative stress workflows. It connects the defined compound format and handling requirements with published porcine oocyte data while clarifying assay controls, interpretation limits, and practical vendor-selection criteria.

• How Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-22

  Song et al. show that murine norovirus exploits the host membrane-rupture factor NINJ1 to release the viral immune-modulatory protein NS1 through an unconventional secretion pathway. The study links caspase-3 cleavage, NINJ1 recruitment to viral replication sites, and selective NS1 release to intestinal infection in mice, offering a mechanistic framework for viral control of programmed cell death.

• MG-132 Workflows for Apoptosis and Cell-Cycle Studies

  2026-08-21

  MG-132 provides a fast, tunable way to disrupt proteasome function for apoptosis assays, cell-cycle arrest studies, oxidative stress profiling, and cancer research. This guide connects practical dose-finding and handling choices with a reference model showing how proteasome inhibition can help separate RIPK3-dependent cell-death programs from inflammatory signaling.

• Gasdermin C Rewires PDAC Stemness and Immunity

  2026-08-20

  A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a transcriptional regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion through a pyroptosis-independent mechanism. The work links ADAM17-mediated cleavage and nuclear GSDMC fragments to CXCL9-dependent immune remodeling and improved responses to KRASG12D inhibition and PD-1 blockade.

• Isoproterenol Sulfate Dihydrate in Cardiac Models

  2026-08-20

  Isoproterenol sulfate dihydrate, also called Isoproterenol hemisulfate, is a water-soluble non-selective β-adrenergic agonist for controlled studies of beta-adrenergic receptor signaling. Its receptor activity makes it useful for probing cAMP/PKA responses in cardiac, respiratory, and human pacemaker models, but its non-selective pharmacology requires appropriate controls.

• Ibrexafungerp vs Caspofungin in Resistant C. auris

  2026-08-19

  Wiederhold et al. combined isolate-level susceptibility testing with a delayed-treatment murine model to evaluate ibrexafungerp against fluconazole-resistant Candida auris. The study found consistent in vitro activity and meaningful in vivo effects, supporting glucan synthase inhibition as a strategy for invasive candidiasis when therapy cannot begin immediately.

• (-)-JQ1: A Causal Control for BET Studies

  2026-08-19

  (-)-JQ1 is an inactive JQ1 stereoisomer that helps separate BET-dependent biology from stereochemistry-independent assay effects. This article develops a causal, cell-to-animal framework for using it in epigenetics research and cancer biology research.

444 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page